Page 356 - Small Animal Internal Medicine, 6th Edition
P. 356

328    PART II   Respiratory System Disorders


            require relatively high dosages of prednisone, have unaccept-  may confer an additional benefit of mild antiinflammatory
            able adverse effects, or have conditions for which glucocor-  properties. The ability of doxycycline to reach therapeutic
  VetBooks.ir  ticoids are relatively contraindicated (e.g., diabetes mellitus)   concentration within the airways is questionable because in
                                                                 the dog it is highly protein bound, but the presence of inflam-
            may benefit from local treatment with metered dose inhalers
            (MDIs). This route of administration is discussed in greater
                                                                 the drug. It is preferable to reserve fluoroquinolones for cases
            detail later in this chapter, in the section on feline   matory cells may increase locally available concentrations of
            bronchitis.                                          of serious infection.
              Cough suppressants are used cautiously because cough is   If an antibiotic is effective, a positive response is generally
            an important mechanism for clearing airway secretions. In   seen within 1 week. Treatment is then continued for at least
            some dogs, however, the cough is incessant and exhausting,   1 week beyond the time when the clinical signs stabilize
            or ineffective, because of marked tracheobronchomalacia.   because complete resolution is unlikely in these animals.
            Cough suppressants can provide significant relief for such   Antibiotic treatment usually is necessary for 3 to 4 weeks.
            animals and may even facilitate ventilation and decrease   Even longer treatment may be necessary in some cases, par-
            anxiety. Although the doses given in Table 21.1 are the ones   ticularly if bronchiectasis or overt pneumonia is present. The
            that provide prolonged effectiveness, less frequent adminis-  use of antibiotics for the treatment of respiratory tract infec-
            tration (i.e., only during times of the day when coughing is   tion is also discussed in the section on CIRDC in this chapter
            most severe) may preserve some beneficial effect of cough.   and in the section on bacterial pneumonia in Chapter 22.
            For dogs with severe cough, hydrocodone may provide the   Tracheobronchomalacia is discussed later in this chapter,
            greatest relief.                                     and pulmonary hypertension is discussed in Chapter 22.
              Maropitant may be considered as a cough suppressant in
            dogs that cannot tolerate even low dosages of narcotic anti-  Prognosis
            tussives. Although there was no benefit in reducing airway   Canine chronic bronchitis cannot be completely cured. The
            inflammation,  Grobman  and Reinero (2016)  reported  a   prognosis for the control of signs and for a satisfactory
            decrease in cough as described by owners of dogs with bron-  quality of life in animals is good if owners are conscientious
            chitis. Maximal effect may not be seen before 1 to 2 weeks   about performing the medical management aspects of care
            of treatment.                                        and are willing to adjust treatment over time and treat sec-
                                                                 ondary problems as they occur.
            MANAGEMENT OF COMPLICATIONS
            Antibiotics are often prescribed for dogs with chronic bron-
            chitis. If possible, confirmation of infection and antibiotic   FELINE BRONCHITIS (IDIOPATHIC)
            sensitivity information should be obtained by culture of an
            airway specimen (e.g., tracheal wash fluid). Because cough in   Etiology
            dogs with chronic bronchitis often waxes and wanes in sever-  Cats with respiratory disease of many origins present with
            ity, it is difficult to make a diagnosis of infection on the basis   signs of bronchitis or asthma. Cat airways are much more
            of the patient’s response to therapy. Furthermore, organ-  reactive and prone to bronchoconstriction than those of
            isms involved in bronchial infections generally originate   dogs. The common presenting signs of bronchitis (i.e., cough,
            from the oropharynx. They are frequently gram-negative   wheezing, and/or respiratory distress) can occur in cats with
            with unpredictable antibiotic sensitivity patterns. The role   diseases as varied as lung parasites, heartworm disease, aller-
            of  Mycoplasma organisms in canine chronic bronchitis is   gic bronchitis, bacterial or viral bronchitis, toxoplasmosis,
            not well understood. They may be an incidental finding, or   idiopathic pulmonary fibrosis, carcinoma, and aspiration
            they may be pathogenic. Ideally, antibiotic selection is based   pneumonia (Table 21.2). Veterinarians often assume that cats
            on results of culture. Antibiotics that are generally effec-  with presenting signs of bronchitis or asthma have idiopathic
            tive against Mycoplasma include doxycycline, azithromycin,   disease because in most cats an underlying cause cannot be
            chloramphenicol, and fluoroquinolones.               found. However, as with canine chronic bronchitis, a diag-
              In addition to the susceptibility of identified organisms,   nosis of idiopathic feline bronchitis can be made only by
            the ability of candidate antibiotics to penetrate the airway   ruling out other active disease. Care should be taken when
            secretions to the site of infection should be considered when   using the terms feline bronchitis or feline asthma to distin-
            selecting an antibiotic. Antibiotics that are likely to reach   guish between a presentation consistent with bronchitis in
            concentrations effective against susceptible organisms   a broad sense and a clinical diagnosis of idiopathic disease.
            include fluoroquinolones, azithromycin, chloramphenicol,   Cats with idiopathic bronchitis often have some degree of
            and possibly amoxicillin with clavulanate. β-Lactam antibi-  airway eosinophilia, typical of an allergic reaction. This
            otics do not generally reach therapeutic concentrations in   author prefers to reserve the diagnosis of allergic bronchitis
            airway secretions of healthy (not inflamed) subjects. If used   for patients who respond dramatically to the elimination of
            for bronchial infection, the high end of the dosage range   a suspected allergen (see the section on allergic bronchitis
            should be used.                                      later in this chapter).
              Doxycycline is often recommended because Mycoplasma   A wide variety of pathologic processes can affect indi-
            and many Bordetella isolates are susceptible to this drug. It   vidual cats with idiopathic bronchitis. Clinically, the range in
   351   352   353   354   355   356   357   358   359   360   361